Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.61 USD | -0.48% | -1.90% | +43.32% |
05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.32% | 1.57B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.50% | 21.93B | |
-12.15% | 22.34B | |
-5.57% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology Says Lung Cancer Combination Therapy Showed Anti-tumor Activity in Preclinical Trial